唐氏综合征合并阻塞性睡眠呼吸暂停患者腺样体扁桃体切除术后的结局
本文通过系统综述与病例系列,评估唐氏综合征(DS)合并阻塞性睡眠呼吸暂停(OSA)患者行腺样体扁桃体切除术(T&A)后的多导睡眠图(PSG)结局。综述纳入6篇文章,显示T&A后有一定改善但常残留疾病。本机构病例系列中,术前呼吸暂停低通气指数(AHI)中位数13.75(四分位距6.65-23.43)改善至术后3.5(四分位距1.96-9.63),P=0.004;术前AHI<5者占10%,术后增至60%;术后AHI<1者占20%。
要点
- 综述6篇文章显示T&A后OSA有一定改善,但患者常残留疾病。
- 本机构病例系列中,AHI中位数从术前13.75改善至术后3.5(P=0.004)。
- 作者认为T&A应作为DS合并OSA儿童的一线治疗建议,但单一治疗可能不足。
核心结论
- 医学文献中针对DS患者T&A治疗OSA疗效的客观数据很少;患者T&A后睡眠参数有客观改善;T&A应作为DS合并OSA儿童的一线治疗建议,但需注意单一治疗可能不足;未来需利用客观指标的研究进一步量化该人群的疗效。
研究设计与样本
- 系统综述:检索PubMed-NCBI、Scopus、Ovid、EBSCO、Cochrane和EMBASE数据库,纳入报告DS患者T&A治疗OSA后客观结局的文章,并评估证据等级与偏倚。
- 病例系列:在三级学术中心对确诊DS合并OSA的患者进行病例系列研究,通过比较治疗前后PSG数据评估T&A疗效。
主要发现
- 共识别6篇文章,显示T&A治疗OSA后有一定改善,但受试者常残留疾病。
- 本机构病例系列中,术前AHI为13.75(四分位距6.65-23.43),术后为3.5(四分位距1.96-9.63),P=0.004。
- 术前AHI<5的患者占10%,术后该比例增至60%;术后AHI<1的患者占20%。
临床怎么用
- 作者认为,T&A应作为DS合并OSA儿童的一线治疗建议,同时需注意单一治疗可能不足。
局限性
- 医学文献中针对DS患者T&A治疗OSA疗效的客观数据很少。
- 未来需利用客观指标的研究进一步量化该人群的疗效。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To review the literature for studies examining polysomnography (PSG) outcomes in patients with Down syndrome (DS) and obstructive sleep apnea (OSA) following adenotonsillectomy (T&A), and to review our experience with these patients. DATA SOURCES: PubMed-NCBI, Scopus, Ovid, EBSCO, Cochrane, and EMBASE databases; tertiary academic center medical records. REVIEW METHODS: A systematic review of the medical literature identified articles reporting objective outcomes following T&A for OSA treatment in patients with DS. Articles were critically appraised to assess level of evidence and bias, and the results of articles were summarized. A case series of confirmed patients with DS and OSA was conducted, evaluating T&A efficacy by comparing pre- and posttreatment PSG data. RESULTS: Six articles were identified, which demonstrated some improvement after T&A in the treatment of OSA; however, subjects frequently had persistent disease. At our institution, preoperative Apnea-Hypopnea Index (AHI) improved from 13.75 (interquartile range [IQR] = 6.65-23.43) to 3.5 (IQR = 1.96-9.63) postoperatively; P = 0.004. Ten percent of patients had preoperative AHIs < 5; this proportion increased to 60% following surgery. Twenty percent of patients had postoperative AHIs < 1. CONCLUSION: There is little objective data in the medical literature addressing T&A efficacy in treating OSA in patients with DS patients. Patients show objective improvement in sleep parameters following T&A for OSA. Adenotonsillectomy should be suggested as a first-line treatment for children with DS and OSA, keeping in mind that monotherapy may be insufficient. Future studies utilizing objective measures are required to further quantify the effect in this patient population. LEVEL OF EVIDENCE: Laryngoscope, 127:1465-1470, 2017.
引用
- Farhood Z, Isley JW, Ong AA, et al. Adenotonsillectomy outcomes in patients with Down syndrome and obstructive sleep apnea. Laryngoscope. 2017. PMID: 28055122. doi:10.1002/lary.26398
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。